Molecular pathogenesis of alpha-1-antitrypsin deficiency.

Rev Mal Respir

Department of Medicine, University of Cambridge, Cambridge Institute for Medical Research, Wellcome Trust/MRC Building, Hills Road, Cambridge, CB2 0XY, UK. Electronic address:

Published: December 2014

Alpha-1 antitrypsin (α1-AT) is the most abundant circulating protease inhibitor. The common severe Z allele of α1-AT (Glu342Lys) causes the protein to form ordered polymers that are retained within the endoplasmic reticulum of hepatocytes. These polymers form the periodic acid-Schiff positive inclusions that are associated with cirrhosis. The lack of circulating α1-AT predisposes the Z α1-AT homozygote to early onset emphysema. We review here the molecular basis of α1-AT deficiency and show how understanding the liver disease provides new insights in the pathobiology of the associated emphysema. The mechanism of α1-AT deficiency provides a paradigm for a wider group of conditions that we have termed the serpinopathies. We also examine the strategies that are being pursued to develop novel therapies for α1-AT deficiency. This review considers our understanding of the pathobiology of α1-AT deficiency and then illustrate the therapeutic possibilities that can ensue once we understand basic mechanisms of disease.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.rmr.2014.03.015DOI Listing

Publication Analysis

Top Keywords

α1-at deficiency
16
α1-at
8
deficiency
5
molecular pathogenesis
4
pathogenesis alpha-1-antitrypsin
4
alpha-1-antitrypsin deficiency
4
deficiency alpha-1
4
alpha-1 antitrypsin
4
antitrypsin α1-at
4
α1-at abundant
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!